BeiGene, Ltd. (BGNE) has a market capitalization of $20.21B and trades at $184.71. The 52-week range is 126.9681-248.16.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 5.4, Earnings Per Share (EPS) of $34.19, annual revenue of $5.34B.
The stock has a beta of 0.63, operates in the Healthcare sector.
